Cargando…

The pan-cancer lncRNA MILIP links c-Myc to p53 repression

We have recently identified the MYC proto-oncogene, bHLH transcription factor (MYC, best known as c-Myc)-responsive pan-cancer lncRNA c-Myc-Inducible Long noncoding RNA Inactivating P53 (MILIP) as an oncogenic driver. Our studies show that MILIP facilitates tumor protein p53 (TP53, best known as p53...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yu Chen, Zhao, Xiao Hong, Teng, Liu, Thorne, Rick F., Jin, Lei, Zhang, Xu Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Author’s Views
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849729/ https://www.ncbi.nlm.nih.gov/pubmed/33553602 http://dx.doi.org/10.1080/23723556.2020.1842714

Ejemplares similares

c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis
por: Feng, Yu Chen, et al.
Publicado: (2020)

The N-Myc-responsive lncRNA MILIP promotes DNA double-strand break repair through non-homologous end joining
por: Wang, Pei Lin, et al.
Publicado: (2022)

LncRNA MILIP links YBX1 to translational activation of Snai1 and promotes metastasis in clear cell renal cell carcinoma
por: Wang, Yanliang, et al.
Publicado: (2022)

Unraveling the therapeutic potential of the LncRNA-dependent noncanonical Hedgehog pathway in cancer
por: Xing, Zhen, et al.
Publicado: (2015)

p53 isoforms change p53 paradigm
por: Bourdon, JC
Publicado: (2014)

ADHFE1 is a MYC-linked oncogene that induces metabolic reprogramming and cellular de-differentiation in breast cancer
por: Mishra, Prachi, et al.
Publicado: (2018)

Cdk6: At the interface of Rb and p53
por: Nebenfuehr, Sofie, et al.
Publicado: (2018)

Endosome traffic machinery meets the p53–p21 axis
por: Barroso-González, Jonathan, et al.
Publicado: (2014)

Treating cancer when pRb and p53 cannot be reactivated
por: Zhu, Liang
Publicado: (2015)

The PVT1-MYC duet in cancer
por: Tseng, Yuen-Yi, et al.
Publicado: (2015)

Targeting MYC through WDR5
por: Thomas, Lance R., et al.
Publicado: (2020)

Cytoplasmic MYC is an anti-necroptotic protein
por: Lee, Eun-Woo, et al.
Publicado: (2020)

TRIM32 is a novel negative regulator of p53
por: Liu, Juan, et al.
Publicado: (2014)

Role of c-MYC in tumor-associated macrophages and cancer progression
por: Pello, Oscar M., et al.
Publicado: (2013)

Do changes in the c-MYC coding sequence contribute to tumorigenesis?
por: Chakraborty, Abhishek A., et al.
Publicado: (2014)

A novel facet of tumor suppression by p53: Induction of tumor immunogenicity
por: Li, Hai, et al.
Publicado: (2012)

The novel partnership of L-GILZ and p53: a new affair in cancer?
por: Ayroldi, Emira, et al.
Publicado: (2014)

Cytoplasmic gain-of-function mutant p53 contributes to inflammation-associated cancer
por: Bellazzo, Arianna, et al.
Publicado: (2015)

Protective role of p53 in doxorubicin-induced cardiomyopathy as a mitochondrial disease
por: Nishi, Masahiro, et al.
Publicado: (2020)

The complex role of SIRT7 in p53 stabilization: nucleophosmin joins the debate
por: Kumari, Poonam, et al.
Publicado: (2021)

PBRM1 suppresses tumor growth as a novel p53 acetylation reader
por: Cai, Weijia, et al.
Publicado: (2020)

p53 and RB1 regulate Hedgehog responsiveness via autophagy-mediated ciliogenesis
por: Cain, Jason E., et al.
Publicado: (2020)

Molecular hallmarks of renal medullary carcinoma: more to c-MYC than meets the eye
por: Msaouel, Pavlos, et al.
Publicado: (2020)

LncRNA IDH1-AS1 links the functions of c-Myc and HIF1α via IDH1 to regulate the Warburg effect
por: Xiang, Shaoxun, et al.
Publicado: (2018)

Inhibiting system x(C)(−) and glutathione biosynthesis – a potential Achilles' heel in mutant-p53 cancers
por: Clemons, Nicholas J., et al.
Publicado: (2017)

Simplifying cancer: binary pan-cancer superclasses stratified by opposite YAP/TEAD effects
por: Pearson, Joel D., et al.
Publicado: (2021)

Potential utility of the pan-Bcl-2 inhibitor GX15–070 (obatoclax) in cancer immunotherapy
por: Kim, Peter S, et al.
Publicado: (2014)

Breaking bad family ties: Pan-ERBB blockers inhibit KRAS driven lung tumorigenesis
por: Moll, Herwig P., et al.
Publicado: (2018)

The PBAF chromatin remodeling complex represses transcription and promotes rapid repair at DNA double-strand breaks
por: Kakarougkas, Andreas, et al.
Publicado: (2015)

WNT-mediated gene gating: a novel principle connecting oncogenic super-enhancers with the nuclear pore to drive pathological expression of MYC
por: Göndör, Anita
Publicado: (2020)

New link between the RNA polymerase II-CTD and replication stress
por: Landsverk, Helga B., et al.
Publicado: (2021)

Linking H1 with chromatin and growth control
por: Munro, Shonagh, et al.
Publicado: (2017)

Gut microbiota and colon cancer: the carbohydrate link
por: Belcheva, Antoaneta, et al.
Publicado: (2014)

Myeloid-derived suppressor cells link inflammation to cancer
por: Wang, Dingzhi, et al.
Publicado: (2014)

Forging a link between oncogenic signaling and immunosuppression in melanoma
por: Khalili, Jahan S., et al.
Publicado: (2013)

Beneficial autoimmunity links primary biliary cholangitis to the avoidance of cholangiocarcinoma
por: Pol, Jonathan G., et al.
Publicado: (2021)

Author Correction: Genetic polymorphisms of lncRNA-p53 regulatory network genes are associated with concurrent chemoradiotherapy toxicities and efficacy in nasopharyngeal carcinoma patients
por: Wang, Youhong, et al.
Publicado: (2017)

Decoding the noncoding: Prospective of lncRNA-mediated innate immune regulation
por: Li, Zhonghan, et al.
Publicado: (2014)

NKG2D ligands link oncogenic RAS to innate immunity
por: Ho, Samantha S.W., et al.
Publicado: (2013)

Linking apoptosis to cancer metabolism: Another missing piece of JuNK
por: Papa, Salvatore, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dc6a1jgc1v9vam2icudfmgjr64